(Q46498811)

English

Design, synthesis, ADME properties, and pharmacological activities of β-alanyl-D-histidine (D-carnosine) prodrugs with improved bioavailability

scientific article published in June 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/21634010

Design, synthesis, ADME properties, and pharmacological activities of β-alanyl-D-histidine (D-carnosine) prodrugs with improved bioavailability (English)

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/21634010

1 reference

based on heuristic

inferred from title

bioavailability

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/21634010

3

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/21634010

object named as

Marica Orioli

1

0 references

object named as

Marina Carini

10

0 references

Giancarlo Aldini

object named as

Giancarlo Aldini

11

0 references

Alessandro Pedretti

4

object named as

Alessandro Pedretti

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/21634010

author name string

Annunziata Lapolla

5

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/21634010

Giuseppe Rossoni

6

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/21634010

Renato Canevotti

7

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/21634010

Luca Gamberoni

8

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/21634010

Massimo Previtali

9

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/21634010

publication date

1 June 2011

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/21634010

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/21634010

6

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/21634010

7

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/21634010

1269-1282

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/21634010

Signaling and cytotoxic functions of 4-hydroxyalkenals.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100042

21 January 2018

Reactive oxygen species and alpha,beta-unsaturated aldehydes as second messengers in signal transduction

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100042

21 January 2018

Systems analysis of protein modification and cellular responses induced by electrophile stress

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100042

21 January 2018

Protein carbonylation, cellular dysfunction, and disease progression

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100042

21 January 2018

Intervention strategies to inhibit protein carbonylation by lipoxidation-derived reactive carbonyls.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100042

21 January 2018

Lipoxidation-derived reactive carbonyl species as potential drug targets in preventing protein carbonylation and related cellular dysfunction

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100042

21 January 2018

The role of AGEs in aging: causation or correlation

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100042

21 January 2018

Protein carbonylation in human diseases

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100042

21 January 2018

Advanced glycation and advanced lipoxidation: possible role in initiation and progression of diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100042

21 January 2018

Role of lipids in chemical modification of proteins and development of complications in diabetes

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100042

21 January 2018

Biological significance of protein modifications in aging and calorie restriction.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100042

21 January 2018

Aldehyde sources, metabolism, molecular toxicity mechanisms, and possible effects on human health

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100042

21 January 2018

Role of oxidative carbonylation in protein quality control and senescence

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100042

21 January 2018

Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100042

21 January 2018

4-hydroxynonenal and neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100042

21 January 2018

Glycoxidation and lipoxidation in atherogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100042

21 January 2018

Carnosine is a quencher of 4-hydroxy-nonenal: through what mechanism of reaction?

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100042

21 January 2018

HNE Michael adducts to histidine and histidine-containing peptides as biomarkers of lipid-derived carbonyl stress in urines: LC-MS/MS profiling in Zucker obese rats.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100042

21 January 2018

Modeling of the intestinal peptide transporter hPepT1 and analysis of its transport capacities by docking and pharmacophore mapping

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100042

21 January 2018

Oral delivery of peptide drugs: barriers and developments.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100042

21 January 2018

Current ocular drug delivery challenges for N-acetylcarnosine: novel patented routes and modes of delivery, design for enhancement of therapeutic activity and drug delivery relationships

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100042

21 January 2018

Multiple peaking phenomena in pharmacokinetic disposition.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100042

21 January 2018

Olmesartan ameliorates renovascular injury and oxidative stress in Zucker obese rats enhanced by dietary protein

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100042

21 January 2018

Low-molecular weight advanced glycation end products: markers of tissue AGE accumulation and more?

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100042

21 January 2018

The AGE inhibitor pyridoxamine inhibits lipemia and development of renal and vascular disease in Zucker obese rats

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100042

21 January 2018

Carnosine protects proteins against methylglyoxal-mediated modifications.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100042

21 January 2018

Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100042

21 January 2018

Protective effects of antioxidant-fortified diet on renal function and metabolic profile in obese Zucker rat.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100042

21 January 2018

LC-ESI-MS/MS determination of 4-hydroxy-trans-2-nonenal Michael adducts with cysteine and histidine-containing peptides as early markers of oxidative stress in excitable tissues.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100042

21 January 2018

VEGA: a versatile program to convert, handle and visualize molecular structure on Windows-based PCs.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100042

21 January 2018

Homology modeling and metabolism prediction of human carboxylesterase-2 using docking analyses by GriDock: a parallelized tool based on AutoDock 4.0.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100042

21 January 2018

Acrolein‐sequestering ability of endogenous dipeptides: characterization of carnosine and homocarnosine/acrolein adducts by electrospray ionization tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100042

21 January 2018

Peroxynitrite reactivity with amino acids and proteins

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100042

21 January 2018

Homology Modeling of Human Serum Carnosinase, a Potential Medicinal Target, and MD Simulations of Its Allosteric Activation by Citrate

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100042

21 January 2018

In silico prediction of human carboxylesterase-1 (hCES1) metabolism combining docking analyses and MD simulations

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100042

21 January 2018

Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100042

7 January 2021

based on heuristic

inferred from DOI database lookup

Carnosine reacts with a glycated protein

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100042

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CMDC.201100042

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/21634010

release_afnva36kmnbrfeigdul5jouloq

1 reference

https://api.fatcat.wiki/v0/release/afnva36kmnbrfeigdul5jouloq

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/21634010

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46498811&oldid=2114445729"